paclitaxel has been researched along with Femoral Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberghini, M; Antonescu, CR; Bertoni, F; Cesari, M; Ferrari, C; Ferrari, S; Maki, RG; Marchesi, E; Mavrogenis, A; Paioli, A; Palmerini, E; Picci, P; Ruggieri, P; Staals, EL | 1 |
Arano Bermejo, JI; Cabañas Navarro, L; Capote Armas, LF; González-Palacios Martínez, F; Reguero Callejas, ME; Ruiz Tovar, J | 1 |
2 other study(ies) available for paclitaxel and Femoral Neoplasms
Article | Year |
---|---|
Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutions.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cohort Studies; Disease-Free Survival; Doxorubicin; Female; Femoral Neoplasms; Femur; Hemangiosarcoma; Humans; Humerus; Ifosfamide; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pelvic Bones; Radiotherapy; Radiotherapy, Adjuvant; Radius; Retrospective Studies; Skull Neoplasms; Spinal Neoplasms; Treatment Outcome; Ulna; Young Adult | 2014 |
Malignant mixed Mullerian tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Fatal Outcome; Female; Femoral Neoplasms; Humans; Hysterectomy; Ifosfamide; Ilium; Middle Aged; Mixed Tumor, Mullerian; Neoplasms, Second Primary; Ovariectomy; Paclitaxel; Palliative Care; Pelvic Neoplasms; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Spinal Neoplasms; Uterine Neoplasms | 2006 |